RNA sequencing

The University of Virginia awarded contract A207_PO-0440509-V3 to Novogene Corporation Inc. on August 15, 2026. The prime contractor will deliver ribonucleic acid (RNA) sequencing services to the University of Virginia as the buyer. The contract specifies delivery on an individual unit basis, with a unit price of one per service rendered. The specific financial terms, including total contract amount, annual value, and cumulative value, are not disclosed in the available documentation.

The scope of work encompasses RNA sequencing capabilities to support the University of Virginia's research or operational requirements within the Commonwealth of Virginia. While the exact period of performance and specific place of performance location are not detailed in the provided materials, the contract represents a service procurement by a major Virginia research institution from a specialized life sciences contractor. Additional contract execution details, including performance schedules and final pricing structures, are not available in the current award documentation.